NCT04301089View on ClinicalTrials.gov

Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

February 4, 2025

Study Completion Date

February 4, 2025

Conditions

Anxiety

Interventions

DEVICE

Pico G2 4K Headset with Applied VR software

headset worn at time points defined in study

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT04301089 - Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients | Biotech Hunter | Biotech Hunter